Caxton Associates (New York)’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-66,055	Closed	-$990K	–	560
2022 Q4	$990K	Buy	+66,055	New	+$990K	0.07%	103